rev bras hematol hemoter. 2015;37(1):69–70
Revista
Brasileira
de
Hematologia
e
Hemoterapia
Brazilian
Journal
of
Hematology
and
Hemotherapy
w w w . r b h h . o r g
Letter
to
the
Editor
To
follow
or
not
to
follow
the
recommendations
regarding
microscopic
analysis
of
the
Clinical
and
Laboratory
Standards
Institute
H20-A2
to
validate
the
criteria
for
blood
smear
review?
DearEditor,
WereadwithgreatinteresttheLettertotheEditorbyGrotto1
ontheneedtofollowtheClinicalandLaboratoryStandards Institute2007H20-A22guidelinesduringmicroscopic
analy-sisinreplytothestudybyComaretal.3 Weappreciatethe
commentsthatensuredextensivediscussiononthissubject. Thework ofBarnesetal.,4 whichrepresentsthecoreof
the criteriaforblood smear review(BSR)recommended by theInternational SocietyforLaboratoryHematology (ISLH), emanatesfromaninternationalconsensusamong20experts in 2002 during a conference in Indian Wells, CA, USA. In consensus,Barnesetal.4 proposedanine-stepprotocol for
validatingtheBSRcriteriainroutinelaboratorypractices.Step 4ofthisprotocolisasfollows:“Performaslidereviewofall samples.Limitthereviewstoonlyoneortwosenior tech-nologistsforconsistency.Manualdifferentialsshouldonlybe performedifthereisaspecificneedtodoso(e.g.,Voteout, abnormalcell-typeflags,etc.)”
Thestep-wiseprotocolbyBarnesetal.4doesnotmention
theNCCLSH20-A5asasinequanonconditionforthe
micro-scopicreviewofbloodsmears.Intheirwork,Barnesetal.4did
notmandatetheapplicationoftheNCCLSH20-A5guidelines,
asinterpretedbyGrotto.1Thus,Barnesetal.4didnotexclude
thepossibilityofoneobservercounting100cellstovalidate theBSRcriteria.Wethereforeunderstandthatcounting per-formedbyeitheroneortwoobserversisequallyacceptable.
TheCLSIH20-A22(formerlyNCCLSH20-A)5isareference
document to evaluate hematology analyzers that perform automated leukocyte differential counts and consider the visualleukocytedifferentialcountasthegoldstandard.Most studies that rigorously followed this guideline specifically evaluatedtheautomatedleukocytedifferentialcountandthe suspectflags ofthe hematology analyzers.6,7 On the other
hand,studiesevaluatingsetsofcriteriaforBSRdidnot nec-essarilyfollowtherecommendationsoftheNCCLSH20-A5or
CLSIH20-A22regardingthemicroscopicanalysis.4,8–11Thus,
weemphasizethat,inthestudyofComaretal.3thestep-wise
rulesofBarnesetal.4thatexclusivelydealwiththevalidation
oftheBSRcriteriawerefollowed.
WebelievethatBarnesetal.4recommendedslidereviewby
eitheroneortwoobservers,withoutspecifyingasetnumber ofslidespersamplenorthenumberofcellstobecountedper slide,toenableapplicationofthesameprotocolsofsample collectionandprocessingasinroutineprotocolsfor valida-tionpurpose,thussimulatingthereal-timeconditionsofmost hematologylaboratories.
WeevaluatedthecriteriaforBSRbyusingthehematology analyzersprovidedbySysmexCorporation.3Theapplication
of the criteriafor BSR adaptedfrom ISLHresulted in high falsenegative(FN)(>5%)andmicroscopicreviewrates(MRR). SimilarresultswerereportedbyXingetal.12inananalysis
of2400samplesusingtheADVIA120/2120hematology ana-lyzer,accordingtothescreeningcriteriaproposedbyISLHand theirown positivesmearfindings[FN=5.5%,falsepositives (FP)=28.1%,and MRR=50.2%]. Itisimportanttoemphasize that we did not conclude “the inadequate performanceof bothpiecesofequipment”inanyinstanceoftheproposals byComaretal.3Weexplainedthat30%oftheFPresults(i.e.,
6.98%ofthetotalsamplesor138samplesin1977)occurred duetothepresenceofsuspectflagsinthesamples.This per-centagerepresentsthesumofallsuspectflagsgeneratedin allsamplesandwhosemicroscopiccounterpartdidnot pro-videanypositivesmearfinding.WebelievethattheFPrates observedbyComaret al.3canbepartiallyattributedtothe
70
rev bras hematol hemoter. 2015;37(1):69–70Inourexperience,inindividualanalysis,themainsuspect flagsdeliveredthefollowingresultsusingtheXE-2100D hema-tologyanalyzerforsamplessimilartothoseusedbyComar etal.3:TheFNrateandefficiencyforimmaturegranulocytes
were1.15%and94.71%;theFNrateforblastswas0.17%(n=3 samples);andtheefficiency,sensitivity,andspecificityforLeft Shiftwere82.4%,44%,and92.08%,respectively.13Therefore,
unlikeGrotto’s(1)interpretation,theperformancesofthese suspectflagswerealmostsimilartothosereportedby Stam-mingeretal.6andRuzickaetal.14
Insummary,eachlaboratoryshouldestablishitsown cri-teriaforBSRofbloodcountsaccordingtotheirpeculiarities, possibilities,andlimitations,anditshouldfollowthe appro-priateguidelinesandtoolstovalidatesuchcriteriainroutine laboratorypractices.Afteracarefulanalysisoftheresults dis-cussedabove,weconcludethattheuseoftherulesproposed byBarnesetal.4wasadequateinthestudyofComaretal.3
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
r
e
f
e
r
e
n
c
e
s
1. GrottoHZ.Whyandhowvalidatethecriteriaformanual smearreviewforimprovingthelaboratoryproductivity?Rev BrasHematolHemoter.2014.thisissue.
2. ClinicalandLaboratoryStandardsInstitute(CLSI).Reference leukocyte(WBC)differentialcount(proportional)and evaluationofinstrumentmethods:approvedstandard.2nd ed.Wayne,PA:CLSI;2007.DocumentH20-A2.
3. ComarSR,MalvezziM,PasquiniR.Arethereviewcriteriafor automatedcompletebloodcountsoftheInternational SocietyofLaboratoryHematologysuitableforallhematology laboratories?RevBrasHematolHemoter.2014;36(3):219–25.
4. BarnesPW,McfaddenSL,MachinSJ,SimsonE.The internationalconsensusgroupforhematologyreview: suggestedcriteriaforactionfollowingautomatedCBCand WBCdifferentialanalysis.LabHematol.2005;11(2):83–90.
5. NationalCommitteeforClinicalLaboratoryStandards (NCCLS).Referenceleukocyte(WBC)differentialcount (proportional)andevaluationofinstrumentmethods: approvedstandard.Villanova,PA:NationalCommitteefor ClinicalLaboratoryStandards;1992.DocumentH20-A.
6. StammingerG,AuchD,DiemH,SinhaP.Performanceofthe XE-2100leukocytedifferential.ClinLabHaematol.
2002;24(5):271–80.
7.JonesRG,FaustA,GlazierJ,MatthewsR,PotterB.Cell-Dyn 4000:utilitywithinthecorelaboratorystructureand preliminarycomparisonofitsexpandeddifferentialwiththe 400-cellmanualdifferentialcount.LabHematol.1998;4:34–44.
8.ComarSR,MalvezziM,PasquiniR.Establishmentand evaluationofreviewcriteriaofautomatedcompleteblood countsapplyingreceiveroperatingcharacteristics(ROC) curveanalysis.IntJLabHematol.2013;35Suppl.1:44–5.
9.LantisKL,HarrisRJ,DavisG,RennerN,FinnWG.Elimination ofinstrument-drivenreflexmanualdifferentialleukocyte counts.Optimizationofmanualbloodsmearreviewcriteria inahigh-volumeautomatedhematologylaboratory.AmJ ClinPathol.2003;119(5):656–62.
10.PratumvinitB,WongkrajangP,ReesukumalK,KlinbuaC, NiamjoyP.Validationandoptimizationofcriteriaformanual smearreviewfollowingautomatedbloodcellanalysisina largeuniversityhospital.ArchPatholLabMed.
2013;137(3):408–14.
11.FroomP,HavisR,BarakM.Therateofmanualperipheral bloodsmearreviewsinoutpatients.ClinChemLabMed. 2009;47(11):1401–5.
12.XingY,WangJZ,PuCW,ShangK,YanZL,BaiWS,etal. EstablishmentandevaluationofreviewcriteriaforADVIA 120/2120anddifferentseriesofhematologyanalyzers. ZhonghuaYiXueZaZhi.2010;90(22):1526–30.
13.ComarSR,MalvezziM,PasquiniR.Theusefulnessofsuspect flagsontheSysmexXE-2100Dhematologyanalyzer.IntJLab Hematol.2014;36Suppl.1:110.
14.RuzickaK,VeitlM,Thalhammer-ScherrerR,SchwarzingerI. ThenewhematologyanalyserSysmexXE-2100Performance evaluationofanovelwhitebloodcelldifferentialtechnology. ArchPatholLabMed.2001;125(3):391–6.
SamuelRicardoComar∗,MariesterMalvezzi, Ricardo
Pasquini
UniversidadeFederaldoParaná(UFPR),Curitiba,PR,Brazil
∗Correspondingauthorat:LaboratóriodeHematologia,Unidade
deApoioDiagnóstico,HospitaldeClínicas,Universidade Fe-deraldoParaná(UFPR),RuaPadreCamargo,280,AltodaGlória, 80060-240Curitiba,PR,Brazil.
E-mailaddress:srcomar@ufpr.br(S.R.Comar).
Received19September2014 Accepted20September2014 Availableonline21November2014
http://dx.doi.org/10.1016/j.bjhh.2014.11.005